Navigation Links
S*BIO Receives BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award
Date:3/5/2009

SINGAPORE, March 6 /PRNewswire/ -- S*BIO Pte Ltd today announced that it has received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. Dr. Stephen Rhind, Senior Vice President Corporate Development, S*BIO, received the award on behalf of the company, from Mr. S. Iswaran, Singapore's Senior Minister for Trade and Industry.

The Annual BioSpectrum awards recognize outstanding contributions to the growth of the biotechnology and life sciences industry in Asia. S*BIO was chosen for its innovative business model and leading position in Singapore's biotechnology industry.

"We are proud to be named Singapore's emerging bioscience company of the year," said Dr. Jan-Anders Karlsson, CEO of S*BIO. "Receiving this award not only reflects S*BIO's leading role in oncology drug discovery and development but also demonstrates the commitment of Singapore's government to the local biomedical sciences industry.

"We thank everyone at S*BIO whose combined efforts led to the significant progress we made in moving our leading candidates, the JAK2 inhibitors SB1518 and SB1578, the HDAC inhibitor SB939, and the multi-kinase inhibitor SB1317, through pre-clinical and clinical development."

About BioSpectrum

Launched in 2003 by Asia's leading specialty publishing company, CyberMedia India Ltd., BioSpectrum is India's and Asia-Pacific's most widely circulated and read Life Sciences media platform. It comes out in two monthly editions: India edition published from Banglaore and an Asian edition, printed and published from Singapore. The business-to-business magazine tracks the growth of life science companies, captures the emerging technological and entrepreneurial trends in the area of Life Sciences which include pharmaceutical, biotechnology, medical technology, bio-agriculture and bio-fuels. The combined readership of both the editions of the magazine, which is available in m
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
2. S*BIO Completes US$26 Million Equity Financing
3. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
4. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
5. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
6. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
7. Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee
8. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
9. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
10. IlluminOss Medical Receives ISO 13485 Certification
11. Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Exotic Automation & ... the launch of http://www.cng.exoticautomation.com , an ecommerce ... convenient way to purchase genuine OEM replacement CNG, ... , The new website provides owners of fleets ... access to high performance products for their vehicle ...
(Date:5/4/2015)... May 4, 2015 Many of us ... for certain infants with rare, inherited mutations of ... consequences of their impaired immune responses. ... identified an important role for calcium signaling in ... tuberculosis, the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)... TEL AVIV, Israel , May 4, 2015 /PRNewswire/ ... has filed its annual report on Form 20-F for ... U.S. Securities and Exchange Commission ("SEC"). The annual report ... for the development of antibodies in the area of ... antibodies with superior qualities of high specificity and binding ...
(Date:5/4/2015)... 2015 Genedata, a leading provider ... life science research, today announced the release of ... of its enterprise solution for biologics R&D. This ... efficient discovery and development of novel biotherapeutics. Version ... address protein optimization and developability requirements. Genedata will ...
Breaking Biology Technology:Exotic Automation & Supply Launches Ecommerce Website 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 4
... CardioDex announces initial commercial use ... from commercial use of the device on 41 patients at ... and no complications. "We are very excited about these new ... for a major unmet medical need due to the increasing ...
... Pa., May 1, 2012  Discovery Laboratories, Inc. (NASDAQ: ... new pharmacoeconomic analysis demonstrating that the lower rate of ... , when compared with infants treated with Curosurf ® ... leading surfactants, also resulted in a potential hospital cost ...
... 2012 /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX ) ... focused on researching, developing, manufacturing and marketing biopharmaceutical products, ... Report on Form 20-F for the fiscal year ended ... Commission on April 30, 2012. The annual report on ...
Cached Biology Technology:New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy 2New Revolutionary Femoral Access Site Closure Device Shows Unparalleled Efficacy, Safety & Ease of Use, in a Wide Range of Patients Including Patients With a Challenging Anatomy 3Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 2Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 3Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 4Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 5
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... , April 2, 2015 ... DERMALOG by far outperforms the strongest competitors, showing ... high accuracy, the system is capable of a ... speed proves up to be ten times faster ... its runner-up performance.      (Photo: ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... can produce biodiesel fuel from municipal sewage sludge that is ... conventional diesel refined from petroleum, according to an article in ... is the solid material left behind from the treatment of ... out in the article that demand for biodiesel has led ...
... part of a healthy diet, can increase the levels ... cholesterol, according to an international team of nutritional scientists., ... lowering lipids and lipoproteins, which are a risk factor ... nutrition, Penn State. "This new study shows an additional ...
... the lowly lamprey eel have identified an overlooked nervous ... circuitry in vertebrates such as birds, fishes and mammals. ... , online May 16, and highlighted in the magazine,s ... Illinois at Chicago professor of biological sciences and the ...
Cached Biology News:Pistachios offer multiple benefits 2Pistachios offer multiple benefits 3Parallel brainstem circuit discovery suggests new path in Parkinson's research 2
The VersArray hybridization chamber is used for manual (coverslip) hybridization of microarrays. The chamber accommodates 2 slides and is watertight to allow incubation of slides in a water bath. Dim...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... solid. PROTECT FROM LIGHT. Useful in cell activation experiments ... ≥98% by TLC. Soluble in DMSO or EtOH. ... 10 mM stock in DMSO is recommended. Microliter amounts ... O with rapid mixing (e.g. 10 μl into 5 ...
Monoclonal antibodies conjugated with rhodamine...
Biology Products: